UK pharma major AstraZeneca (LSE: AZN) today reported extended approvals in Europe for two of its cancer drugs: Imfinzi ...
US regenerative cell therapy specialist Neurona Therapeutics has announced the successful completion of an upsized and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback